← Leaderboards
Ming Wang
Case Western Reserve University
$656,266
Attributed
$1,312,532
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $671.5K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,312,532 · 1
By mechanism
R01$1,312,532 · 1
Top collaborators
- Mahboob Rahman2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Mahboob Rahman$19,798,180
- Paul Englund Drawz$5,753,262
- Sanjay Rajagopalan$28,940,369
- Jackson Wright$20,229,325
- Carolyn Harmon Still$5,253,566
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAfrican AmericanAfrican AncestryAnalytical MethodAngiotensin-Converting Enzyme InhibitorsAngiotensin ReceptorAnti-Hypertensive AgentsAnti-Inflammatory AgentsAreaBenefits And RisksBiomedical ResearchBiometryBlood PressureBlood Pressure InterventionBlood Pressure MedicationBlood Pressure ReductionBlood VesselsCalcium ChannelCalcium Channel BlockersCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular EffectsCardiovascular Risk FactorAdult
Grant awards (2)
Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD)$641,016
R01 · FY2025 · HL · contact PI
Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD)$671,516
R01 · FY2024 · HL · contact PI